Sorrento Therapeutics, Inc. Annual Costs and Expenses in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2012 to 2022.
  • Sorrento Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2023 was $92.3M, a 28.9% decline year-over-year.
  • Sorrento Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2023 was $527M, a 6.19% increase year-over-year.
  • Sorrento Therapeutics, Inc. annual Costs and Expenses for 2022 was $567M, a 24.8% increase from 2021.
  • Sorrento Therapeutics, Inc. annual Costs and Expenses for 2021 was $454M, a 59.7% increase from 2020.
  • Sorrento Therapeutics, Inc. annual Costs and Expenses for 2020 was $285M, a 2.17% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $567M +$113M +24.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $454M +$170M +59.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $285M -$6.32M -2.17% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $291M +$119M +69.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $172M +$45.1M +35.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $127M +$21.6M +20.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $105M +$26.3M +33.5% Jan 1, 2016 Dec 31, 2016 8-K 2019-06-17
2015 $78.6M +$40M +104% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $38.6M +$16.4M +74.3% Jan 1, 2014 Dec 31, 2014 10-K/A 2017-03-27
2013 $22.1M +$16.7M +307% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $5.44M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.